SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
23.05
-0.25 (-1.07%)
At close: Sep 4, 2026
ETR:1SXP Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, ETR:1SXP stock has a consensus rating of "Buy" and an average price target of €23.40. The average 1-year stock price forecast is 1.52% higher than the current stock price, while the lowest is €13.00 (-43.60%) and the highest is €27.00 (+17.14%).
Price Target: €23.40 (+1.52%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ETR:1SXP stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 2 | 3 |
| Hold | 5 | 5 | 5 | 5 | 3 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
1.04B
from 986.21M
Increased by 5.42%
Revenue Next Year
1.10B
from 1.04B
Increased by 5.94%
EPS This Year
0.99
from 0.97
Increased by 1.75%
EPS Next Year
1.09
from 0.99
Increased by 10.93%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.